BE901963A - Forme dosee d'etoposide a usage oral. - Google Patents

Forme dosee d'etoposide a usage oral.

Info

Publication number
BE901963A
BE901963A BE0/214666A BE214666A BE901963A BE 901963 A BE901963 A BE 901963A BE 0/214666 A BE0/214666 A BE 0/214666A BE 214666 A BE214666 A BE 214666A BE 901963 A BE901963 A BE 901963A
Authority
BE
Belgium
Prior art keywords
oral use
etoposide
acid
dosed form
etopsoside
Prior art date
Application number
BE0/214666A
Other languages
English (en)
Inventor
S Begum
I Ullah
B C Nunning
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of BE901963A publication Critical patent/BE901963A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Forme dosée liquide propre à l'administration par voie orale de l'étopsoside, qui est suffisamment concentrée pour etre présentée dans une capsule et qui assure une meilleure absorption du médicament comparé à celle atteinte avec les formulations àusage oral déjà connues. La composition pharmaceutique comprend de l'étoposide, du polyéthylèneglycol, de l'acide taurocholique, de l'éthanol et un acide hydrosoluble, qui est par préférence l'acide citrique.
BE0/214666A 1984-03-19 1985-03-18 Forme dosee d'etoposide a usage oral. BE901963A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59114484A 1984-03-19 1984-03-19

Publications (1)

Publication Number Publication Date
BE901963A true BE901963A (fr) 1985-09-18

Family

ID=24365235

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/214666A BE901963A (fr) 1984-03-19 1985-03-18 Forme dosee d'etoposide a usage oral.

Country Status (28)

Country Link
JP (1) JPS60209516A (fr)
KR (1) KR850006136A (fr)
AT (1) AT392904B (fr)
AU (1) AU571308B2 (fr)
BE (1) BE901963A (fr)
CA (1) CA1238578A (fr)
CH (1) CH662731A5 (fr)
DE (1) DE3509741A1 (fr)
DK (1) DK164535C (fr)
EG (1) EG17521A (fr)
ES (1) ES8702140A1 (fr)
FI (1) FI84023C (fr)
FR (1) FR2561104B1 (fr)
GB (1) GB2155789B (fr)
GR (1) GR850688B (fr)
IE (1) IE58340B1 (fr)
IL (1) IL74615A (fr)
IT (1) IT1187640B (fr)
LU (1) LU85812A1 (fr)
MY (1) MY101916A (fr)
NL (1) NL8500739A (fr)
NO (1) NO170569C (fr)
NZ (1) NZ211078A (fr)
OA (1) OA07968A (fr)
PT (1) PT80131B (fr)
SE (1) SE8501312L (fr)
YU (1) YU45243B (fr)
ZA (1) ZA851935B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60239418A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド軟カプセル製剤
JPS61189230A (ja) * 1985-02-19 1986-08-22 Nippon Kayaku Co Ltd エトポシド製剤
DE3629386A1 (de) * 1986-08-29 1988-03-03 Scherer Gmbh R P Gelatinekapseln und verfahren zu ihrer herstellung
US4927638A (en) * 1986-10-08 1990-05-22 Bristol-Myers Company Etoposide solutions
US5154930A (en) * 1987-03-05 1992-10-13 The Liposome Company, Inc. Pharmacological agent-lipid solution preparation
US5376381A (en) * 1988-02-25 1994-12-27 The Liposome Company, Inc. Integrity protected gelatin
JP2000247911A (ja) * 1999-02-26 2000-09-12 Hisamitsu Pharmaceut Co Inc 大腸用吸収促進剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH580255A5 (fr) * 1974-06-04 1976-09-30 Calinter Sa
DE2452785A1 (de) * 1974-11-07 1976-05-13 Universal Oil Prod Co Verfahren zum betrieb einer verbrennungsmaschine
FR2358144A1 (fr) * 1976-07-13 1978-02-10 Lipha Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire
JPS5940137B2 (ja) * 1976-10-14 1984-09-28 武田薬品工業株式会社 経口投与用医薬組成物
FR2410504A1 (fr) * 1977-12-05 1979-06-29 Air Liquide Procede de reglage de securite d'un reacteur chimique et installation de reaction d'oxydation mettant en oeuvre ce procede
DE2809543A1 (de) * 1978-03-06 1979-09-13 Werner Henke Verfahren und vorrichtung zum neutralisieren von gasen bei oel- und gasbohrungen
JPS60239418A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド軟カプセル製剤

Also Published As

Publication number Publication date
IE58340B1 (en) 1993-09-08
JPS60209516A (ja) 1985-10-22
NZ211078A (en) 1987-08-31
IL74615A0 (en) 1985-06-30
KR850006136A (ko) 1985-10-02
DK164535C (da) 1992-11-30
FR2561104A1 (fr) 1985-09-20
MY101916A (en) 1992-02-15
IL74615A (en) 1988-07-31
IE850686L (en) 1985-09-19
SE8501312L (sv) 1985-09-20
FR2561104B1 (fr) 1988-04-08
GB2155789B (en) 1987-10-21
DK164535B (da) 1992-07-13
YU42085A (en) 1988-02-29
NL8500739A (nl) 1985-10-16
AU3897585A (en) 1985-09-26
SE8501312D0 (sv) 1985-03-18
EG17521A (en) 1990-06-30
IT1187640B (it) 1987-12-23
FI851040A0 (fi) 1985-03-15
PT80131A (en) 1985-04-01
DK122285A (da) 1985-09-20
GR850688B (fr) 1985-07-08
GB8506943D0 (en) 1985-04-24
CH662731A5 (de) 1987-10-30
CA1238578A (fr) 1988-06-28
DK122285D0 (da) 1985-03-18
YU45243B (en) 1992-05-28
AT392904B (de) 1991-07-10
LU85812A1 (fr) 1985-12-12
GB2155789A (en) 1985-10-02
PT80131B (pt) 1987-10-20
FI84023B (fi) 1991-06-28
NO851022L (no) 1985-09-20
FI851040L (fi) 1985-09-20
AU571308B2 (en) 1988-04-14
OA07968A (fr) 1987-01-31
ES8702140A1 (es) 1986-12-16
NO170569C (no) 1992-11-04
ZA851935B (en) 1985-10-30
ES541370A0 (es) 1986-12-16
NO170569B (no) 1992-07-27
FI84023C (fi) 1991-10-10
ATA81985A (de) 1990-12-15
DE3509741A1 (de) 1985-09-26
IT8519897A0 (it) 1985-03-14

Similar Documents

Publication Publication Date Title
TNSN99103A1 (fr) Nouveaux derives de l'acide 3-aryl propionique et analogues
IT1270594B (it) Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
FR2523443B1 (fr) Nouvelles formulations pharmaceutiques contenant le coenzyme q10 adaptees pour l'administration topique
BE1002109A3 (fr) Composition pharmaceutique a activite analgesique.
BE885441A (fr) Derives d'agents anti-inflammatoires non steroides, procede de preparation et compositions pharmaceutiques les contenant
IT1207994B (it) Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche.
BE849632A (fr) Composition pharmaceutique pour l'administration orale
FR2601876B1 (fr) Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et de l'acide citrique
BE845613A (fr) Preparations pharmaceutiques pour l'administration orale renfermant un ester-17beta de nandrolone et nouveaux esters- 17beta de nandrolone
PT83896A (fr) Procede pour la preparation de nouveaux conjuges de la vinblas-tine et de ses derives et de compositions pharmaceutiques les contenant
DZ2316A1 (fr) Micro sphères pharmaceutiques d'acide valproique pour administration orale.
BE901963A (fr) Forme dosee d'etoposide a usage oral.
FR2598320B1 (fr) Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques
EP0263493A3 (fr) Préparation pharmaceutique améliorant la résorption gastro-intestinale
FR2581873B1 (fr) Preparations pharmaceutiques a activite anti-hypertensive et cardioprotectrice contenant du verapamil, du triamterene et de l'hydrochlorothiazide
BE1002182A5 (fr) Compositions pharmaceutiques.
FR2283668A1 (fr) Derives de l'acide prostanoique et medicaments qui en contiennent
OA07540A (fr) Nouveaux dérivés de l'acide cyclopropane carboxylique, leur préparation, leur application à la lutte contre les parasites et les compositions les renfermant.
BE877658A (fr) Nouveaux derives acetyleniques de l'androst-4-ene, leur procede de preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant
BE878256A (fr) Nouveaux derives acetyleniques de l'androst-4-ene, leur procede de preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant
IT1060117B (it) 4 alchil diossi alchilen 5 benzil pirimidine, procedimento per la loro preparazione e preparati medicinali
IT8221120A0 (it) Composizione farmaceutica per combattere l'aggregazione delle piastrine.
FR2607005B1 (fr) Compositions pharmaceutiques contenant de l'acide ursodesoxycholique
FR2283670A1 (fr) Derives d'acides 19,20-bis-nor-prostanoique, leur preparation et compositions pharmaceutiques les contenant
FR2592043B1 (fr) 2-chloro-12-(3-dimethylamino-2-methylpropyl)-12h-dibenzo-(d, g) (1, 3, 6)-dioxazocines optiquement actives, procede pour leur preparation et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BRISTOL-MYERS CY

Effective date: 19940331